Rwanda vs Sri Lanka: Hepatitis B surface antigen (HBsAg) prevalence
Rwanda
0.3%
in 2024
Sri Lanka
0.3%
in 2024
Rwanda rank
71st
Sri Lanka rank
71st
Hepatitis B surface antigen (HBsAg) prevalence over time
- Rwanda
- Sri Lanka
How they compare
Rwanda currently reports 0.3% against 0.3% in Sri Lanka, a difference of 0.0%.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Rwanda ahead.
Rwanda ranks 71st and Sri Lanka ranks 71st of 194 countries.
Rwanda has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Rwanda | Sri Lanka | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.3% | 0.3% | 0.0% | Rwanda |
| 2020s | 0.3% | 0.3% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Rwanda or Sri Lanka?
- Rwanda, at 0.3% against 0.3% in Sri Lanka as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Rwanda and Sri Lanka?
- 0.0%, with Rwanda ahead.
- How many years of comparable data are there for Rwanda and Sri Lanka?
- 10 years are reported by both, from 2015 to 2024.
- How do Rwanda and Sri Lanka rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Rwanda ranks 71st and Sri Lanka ranks 71st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.